Global Nuclear Imaging Equipment Market 2019-2023

The nuclear imaging equipment market size has the potential to grow by $858.76 million during 2019-2023, and the market's growth momentum will accelerate during the forecast period because of the steady increase in year-over-year growth. This report provides a detailed analysis of the market by product (SPECT systems, hybrid PET systems, and planar scintigraphy), application (cardiology, oncology, neurology, and others) and geography (Asia, Europe, North America, and ROW). Also, the report analyzes the market's competitive landscape and offers information on several market vendors, including Canon Inc., GE Healthcare Inc., Koninklijke Philips NV, Mediso Ltd., Neusoft Corp., and Siemens Healthcare GmbH.

Some of the key findings from our nuclear imaging equipment market forecast report are summarized below

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from the nuclear imaging equipment market report.

Get a FREE sample now!

Global nuclear imaging equipment industry overview

The field of molecular radiotracer imaging has undergone significant technological advancements which augurs well for the future of brain diagnostics and the evaluation of neurological diseases. PET/CT and PET/MRI have emerged as promising imaging techniques because of the easy availability of integrated MRI components for anatomical co-registration and clinical scanning systems with fully functional computed tomography (CT). The use of F-18-fludeoxyglucose (F-18-FDG) in radiotracer imaging has especially gained popularity in veterinary oncology for individualized tumor diagnostics and treatment. Moreover, recent advancements in video EEG monitoring and increasing access to nuclear imaging modalities have also boosted the use of radiotracer imaging protocols for the presurgical evaluation of MRI-negative veterinary epilepsy patients. Advancements in radiotracers will be one of the significant factors that will fuel the growth of the nuclear imaging equipment market.

Hybrid PET/CT systems are increasingly replacing standalone systems because of their ability to efficiently and accurately correlate molecular and anatomic imaging information of the patient. MRI technology developers are focusing on enhancing the speed of image acquisition to expand the applications of MRI to cardiac imaging and time-resolved contrast enhanced angiography. The development of advanced CT devices with simplified console will boost their demand because of their easy operability, affordable installation cost, and minimal space requirements. Such developments in diagnostic imaging coupled with advances in radiotracers will drive nuclear imaging equipment market growth at a CAGR of over 6% during the forecast period.

Top companies covered in the nuclear imaging equipment market research report

The global nuclear imaging equipment market is fragmented. To help clients improve their market position, the nuclear imaging equipment market report provides an analysis of the market’s competitive landscape and offers information on the products offered by various companies. Moreover, the nuclear imaging equipment market research report also includes information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make most of the upcoming growth opportunities.

The report offers a detailed analysis of several nuclear imaging equipment companies, including:

• Canon Inc.
• GE Healthcare Inc.
• Koninklijke Philips NV
• Mediso Ltd. 
• Neusoft Corp.
• Siemens Healthcare GmbH 

Nuclear imaging equipment market segmentation based on product

• Single-photon emission computed tomography (SPECT) systems
• Hybrid positron emission tomography (PET) systems
• Planar scintigraphy

The SPECT systems market segment will account for the largest nuclear imaging equipment market share. A SPECT scan is used to monitor blood flow through arteries and veins in the brain. SPECT has emerged in clinical applications to detect benign and malignant cancer types. Also. SPECT non-invasive imaging technique is used for the diagnosis of coronary artery diseases. The wide availability, easy accessibility, and less cost of SPECT systems will drive the growth of the nuclear imaging equipment market in this segment.

Nuclear imaging equipment market segmentation based on geographic region

• Asia
• Europe
• North America
• ROW

North America will account for the largest share of the nuclear imaging equipment market throughout the forecast period. Factors such as the rising preference for nuclear imaging technology for treating chronic diseases, advances in radiotracers, FDA-approved radiopharmaceuticals, growing incidence of cancer and CVD, and increasing awareness about the effective use of radiopharmaceuticals will augment the growth prospects of the nuclear imaging market in this region.

Key highlights of the global nuclear imaging equipment market for the forecast years 2019-2023:

• CAGR of the market during the forecast period 2019-2023
• Detailed information on factors that will accelerate the growth of the nuclear imaging equipment market during the next five years
• Precise estimation of the global nuclear imaging equipment market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the nuclear imaging equipment industry across Asia, Europe, North America, and ROW
• A thorough analysis of the market's competitive landscape and detailed information on several vendors
• Comprehensive details of factors that will challenge the growth of nuclear imaging equipment companies 

We can help! Our analysts can customize the nuclear imaging equipment market research report to meet your requirements. Get in touch